MedTrace Logo

Clinical Study for Topical Lupeol in Acne

NCT02205892 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2014-09-29

No results posted yet for this study

Summary

Double-blind, randomized,4-week small-scale clinical trial for lupeol in the treatment of inflammatory and non-inflammatory acne lesions in split face fashion

Conditions

Interventions

DRUG

Lupeol

Patients are supposed to apply 2% lupeol cream to one side of their face two times per day for 4 weeks. Application side is randomly determined.

DRUG

Placebo vehicle

Patients are supposed to apply their control vehicle cream two times per day to the other side of their face for 4 weeks. Application side is randomly determined.

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Principal Investigators

  • Dae Hun Suh, MD · Seoul National University Department of Dermatology

  • Hyuck Hoon Kwon, MD · Seoul National University Department of Dermatology

  • Sun Yong Park · Seoul National University Department of Dermatology

  • Seounguk Min · Seoul National University Department of Dermatology

  • Jae Yoon Jung · Seoul National University Department of Dermatology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-08-31
Primary Completion
2014-09-30
Completion
2014-09-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02205892 on ClinicalTrials.gov